ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors

ContextVision – Strong Q3 with solid sales, good inflow of new customers and first product in digital pathology enters beta-testing phase

ContextVision – Second quarter saw commercial release of first AI-based product, Altumira™, Digital Pathology on track and record sales

ContextVision on track for 2019 commercial product launch within digital pathology

ContextVision on track for 2019 commercial product launch within digital pathology

ContextVision – Strong Q3 sales and positive feedback within digital pathology

ContextVision AB reports strongest ever first quarter

ContextVision AB reports strongest ever first quarter

ContextVision Sees Strong Sales, Major Progress Within R&D in Q4 2017

ContextVision establishes unique platform for future growth within digital pathology   Follow the link: http://www.webbtv.nu/contextvisionq32017 to find the Q3 webcast by CEO Aita Tollstadius STOCKHOLM – October 26, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has heavily invested in developing state-of-the-art competence within artificial intelligence and the development […]